Trial NCT03811418

View at ClinicalTrials.gov 
Org. Study IDs: iOM-110383
Secondary IDs: 2017-004749-25

Last trial update was posted on 2019-11-26

MeSH Interventions

Docetaxel Pertuzumab Trastuzumab Vinorelbine

MeSH Conditions

Breast Neoplasms

Other Conditions

Advanced Breast Cancer HER2-positive Breast Cancer

Stopping Reasons

Study approved with treatment regimen based on current guidelines. However, reimbursement of IMP was not feasible.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID